Myelodysplastic的例句大全

The treatment of myelodysplastic syndromes with the combinations of differentiation inducing agents and androgens or low dose chemotherapy

分化诱导剂联合雄激素或小剂量化疗药物治疗骨髓增生异常综合征

Triptolide-induced Apoptosis in Myelodysplastic Syndromes MUTZ-1 Cells and Its Mechanism

雷公藤内酯醇诱导人骨髓增生异常综合征MUTZ-1细胞凋亡及其机理研究

Analysis of the clinical characteristics of elderly patients with myelodysplastic syndrome

老年骨髓增生异常综合征的临床特征分析

Progress of Experimental Study on Myelodysplastic Syndrome& Review

骨髓增生异常综合征的实验研究进展

Diagnosis and Treatment of Low-Risk Myelodysplastic Syndrome

低危骨髓增生异常综合征的诊断和治疗

Metabonomics Analysis of Traditional Chinese Medicine Patterns in Patients with Myelodysplastic Syndrome

骨髓增生异常综合征中医证型的代谢组学分析

Clinical analysis of 45 patients with myelodysplastic syndrome

骨髓增生异常综合征45例临床观察报告

Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome

282例原发性骨髓增生异常综合征诊断和分型的前瞻性临床研究

The Study of Causes and Therapy of 22 Cases of Pediatric Myelodysplastic Syndrome

骨髓增生异常综合征临床研究&附22例报道

A study of immune state in myelodysplastic syndrome

骨髓增生异常综合征的免疫状态观察

After treatment, all patients were found different improvement of myelodysplastic features in the marrow section.

治疗后，在骨髓组织病理检查中发现所有患者的病态造血功能可有不同程度改善。

objective to determine the clinical significance of preursor clusters from bone marrow smear in myelodysplastic syndrome(mds).

目的探讨骨髓小粒中幼稚细胞簇的出现对骨髓增生异常综合征（MDS）的诊断价值。

objective to determine the clinical significance of preursor clusters from bone marrow smear in myelodysplastic syndrome(mds).

目的探讨骨髓小粒中幼稚细胞簇的出现对骨髓增生异常综合征（MDS）的诊断价值。

objective to determine the clinical significance of preursor clusters from bone marrow smear in myelodysplastic syndrome(mds).

目的探讨骨髓小粒中幼稚细胞簇的出现对骨髓增生异常综合征（MDS）的诊断价值。

objective to determine the clinical significance of preursor clusters from bone marrow smear in myelodysplastic syndrome(mds).

目的探讨骨髓小粒中幼稚细胞簇的出现对骨髓增生异常综合征（MDS）的诊断价值。

objective to determine the clinical significance of preursor clusters from bone marrow smear in myelodysplastic syndrome(mds).

目的探讨骨髓小粒中幼稚细胞簇的出现对骨髓增生异常综合征（MDS）的诊断价值。

we performed a study on efficacy and safety of bortezomib as a single agent in patients with myelodysplastic syndromes ( mds).

我们研究了硼替佐米单药在骨髓增生异常综合征中应用的有效性和安全性。

conditions included myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, and bronchial carcinoma.

疾病可引发脊髓发育不良、脊髓增殖失调，急性髓性白血病和支气管瘤。

chronic myelomonocytic leukemia (cmml) is a hematologic stem cell disorder with myelodysplastic and myeloproliferative characteristics.

慢性粒细胞白血病（CMML）是一种造血干细胞与骨髓增生异常症和骨髓增生性的特点。

bone marrow mesenchymal stem cells derived from patients with myelodysplastic syndrome possess immunosuppressive activity

骨髓增生异常综合征患者的间充质干细胞具有免疫抑制作用